MMitraTender

Erythropoietin Injection: GeM business opportunity

Who buys Erythropoietin Injection on GeM, in which states, how many sellers compete and what wins. Change the filters to match your business.

Live bids: 2Awarded results: 0Live tenders →

What can you do?

GeM categoryErythropoietin Injection
About your business

Live bids + bids closed 2025-11-07 – 2026-11-07 (365 days). Includes imported GeM history.

Live bids
2
Closed in period
3
Awarded results
0
Median winning price (L1)
—
Avg bidders per bid
—

Tenders published per month

Last 12 months, matching your filters

0 Dec 2025
0 Jan 2026
0 Feb 2026
0 Mar 2026
1 Apr 2026
0 May 2026
0 Jun 2026
0 Jul 2026
0 Aug 2026
22 Sept 2026
1 Oct 2026
1 Nov 2026
Show as table
MonthTenders
Dec 20250
Jan 20260
Feb 20260
Mar 20260
Apr 20261
May 20260
Jun 20260
Jul 20260
Aug 20260
Sept 20262
Oct 20261
Nov 20261

How open are these bids?

No EMD needed
33%

based on 3 bids

MSE turnover/experience relaxed
50%

based on 2 bids

Reverse auction
40%

based on 5 bids

Turnover, experience, EMD and exemptions come from bid documents and are still sparse; every share shows how many bids it is based on. Results improve as more history is imported.

Top 10: where to work

Ranked by opportunity score (0–100). Open a row to see why.

  1. 1
    Erythropoietin Injection69/100

    2 live

    Live tenders →Create alert
    Why this score
    Volume
    100
    Momentum
    50
    Low competition (not enough data, neutral)
    50
    Easy criteria
    75
    Order value (not enough data, neutral)
    50
  2. 2
    Metoprolol Tablet57/100

    1 live

    Live tenders →Create alert
    Why this score
    Volume
    39
    Momentum
    100
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
  3. 3
    Desvenlafaxine Tablets57/100

    1 live

    Live tenders →Create alert
    Why this score
    Volume
    39
    Momentum
    100
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
  4. 4
    Lamivudine Tablet57/100

    1 live

    Live tenders →Create alert
    Why this score
    Volume
    39
    Momentum
    100
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
  5. 5
    Entecavir Tablet57/100

    1 live

    Live tenders →Create alert
    Why this score
    Volume
    39
    Momentum
    100
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
  6. 6
    Bicalutamide Tablets (V2)57/100

    1 live

    Live tenders →Create alert
    Why this score
    Volume
    39
    Momentum
    100
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
  7. 7
    Letrozole Tablet57/100

    1 live

    Live tenders →Create alert
    Why this score
    Volume
    39
    Momentum
    100
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
  8. 8
    Imatinib Tablet57/100

    1 live

    Live tenders →Create alert
    Why this score
    Volume
    39
    Momentum
    100
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
  9. 9
    Ondansetron Injection57/100

    1 live

    Live tenders →Create alert
    Why this score
    Volume
    39
    Momentum
    100
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
  10. 10
    Ondansetron Tablet57/100

    1 live

    Live tenders →Create alert
    Why this score
    Volume
    39
    Momentum
    100
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
Show as table
RankNameScoreLive bidsClosed in periodAvg bidders per bidMedian winning price (L1)
1Erythropoietin Injection6923——
2Metoprolol Tablet5710——
3Desvenlafaxine Tablets5710——
4Lamivudine Tablet5710——
5Entecavir Tablet5710——
6Bicalutamide Tablets (V2)5710——
7Letrozole Tablet5710——
8Imatinib Tablet5710——
9Ondansetron Injection5710——
10Ondansetron Tablet5710——
How the opportunity score works

Score = Volume 30% + Momentum 20% + Low competition 25% + Easy criteria 15% + Order value 10%. Each part is 0–100; a part without enough data counts as a neutral 50.

  • Volume: tenders in the period, compared with the biggest row of the list.
  • Momentum: share published in the last 30 days vs the average (100 = twice as fast).
  • Low competition: 2 bidders per bid = 100, 15 or more = 0.
  • Easy criteria: share of read bid documents with no EMD, an MSE/startup exemption or no turnover/experience criterion.
  • Order value: median winning (L1) price, compared with the highest in the list.

Who wins these bids

Top L1 sellers in awarded bids of the period

No awarded results for these filters yet.

AI business advisor

Get a short plan from these numbers: where to start, whom to sell to, what to prepare and the risks.

Erythropoietin Injection on GeM: Buyers, Competition & Winning Prices | Mitra Tender